Novel therapeutic concepts: The epidemic of cardiovascular disease in the developing world: Global implications

European Heart Journal

Volumn 31, Issue 6, 2010, Pages 642-648

  Gersh, Bernard J ^a   Sliwa, Karen ^b   Mayosi, Bongani M ^c   Yusuf, Salim ^d  

^a MAYO CLINIC   (United States)

^b Hatter Institute for Cardiovascular Research   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

Cardiovascular diseases; Developing world; Epidemic; Primary and secondary prevention; Risk factors

Indexed keywords

AIR POLLUTION; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC DISEASE; CLIMATE CHANGE; DIABETES MELLITUS; EPIDEMIC; EXERCISE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MORTALITY; OBESITY; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SOCIOECONOMICS; TERTIARY HEALTH CARE;

ADULT; CARDIOVASCULAR DISEASES; COST OF ILLNESS; DEVELOPING COUNTRIES; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; MORTALITY; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 77954171379     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq030     Document Type: Review

References (86)

1. Fuster V, Voute J. MDGs: chronic diseases are not on the agenda. Lancet 2005; 366:1512-1514.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757.
3. Organization WH. The Global Burden of Disease 2004 Update. http://www.who. int/healthinfo/global-burden-disease/2004-report-update/en/ index.html (March 2009).
4. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York: Trustees of Columbia; 2004.
5. Gaziano T. Global burden of cardiovascular disease. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. Saunders; 2008. pp. 1-22.
6. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004;110: 1236-1244. http://www.unicef.org/publications/index.html (6 January 2010). (Pubitemid 39202339)
7. Sharma A, Sharma K, Mathur KP. Growth pattern and prevalence of obesity in affluent schoolchildren of Delhi. Public Health Nutr 2007;10:485-491.
8. Mayosi B, Flisher A, Lalloo U, Sitas F, Tollman S, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet 2009;374:934-947.
9. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 1986;64:355-391.
10. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971;49:509-538.
11. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-2864.
12. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005;112:3547-3553.
13. Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr 2006;17:164-165.
14. Commerford P, Mayosi B. An appropriate research agenda for heart disease in Africa. Lancet 2006;367:1884-1886.
15. Maguire JH. Chagas' disease\can we stop the deaths? N Engl J Med 2006;355: 760-761.
16. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-476.
17. Mayosi BM. Contemporary trends in the epidemiology and management of cardi-omyopathy and pericarditis in sub-Saharan Africa. Heart 2007;93:1176-1183.
18. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005;112: 3608-3616.
19. Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyo-cardial fibrosis in a rural area of Mozambique. N Engl J Med 2008;359:43-49.
20. Watkins DA, Zuhlke LJ, Engel ME, Mayosi BM. Rheumatic fever: neglected again. Science 2009;324:37.
21. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S. Risk factors associated with myocardial infarction in Africa: the INTER-HEART Africa study. Circulation 2005;112:3554-3561. (Pubitemid 43739532)
22. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006;114:2619-2626.
23. Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol 2009;6: 712-722.
24. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ 1999;161:132-138.
25. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007;50:2128-2132.
26. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116:1942-1951.
27. Nemetz PN, Roger VL, Ransom JE, Bailey KR, Edwards WD, Leibson CL. Recent trends in the prevalence of coronary disease: a population-based autopsy study of nonnatural deaths. Arch Intern Med 2008;168:264-270.
28. Ford ES, Li C, Zhao G, Pearson WS, Capewell S. Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation 2009;120:1181-1188.
29. Notzon FC, Komarov YM, Ermakov SP, Sempos CT, Marks JS, Sempos EV. Causes of declining life expectancy in Russia. JAMA 1998;279:793-800.
30. Plavinski SL, Plavinskaya SI, Klimov AN. Social factors and increase in mortality in Russia in the 1990s: prospective cohort study. BMJ 2003;326:1240-1242.
31. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-931.
32. Diabetes\a global threat. Lancet 2009;373:1735.
33. Group EIS. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-572.
34. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915-922.
35. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, Stewart S. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study 'Heart Awareness Days'. Int J Cardiol 2009; 132:233-239.
36. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, Ohira T, Tanigawa T, Yamagishi K, Nakamura M, Konishi M, Shimamoto T, Iida M, Komachi Y. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. J Am Coll Cardiol 2008;52:71-79.
37. Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol 2009;53:244-253.
38. Robertson TL, Kato H, Gordon T, Kagan A, Rhoads GG, Land CE, Worth RM, Belsky JL, Dock DS, Miyanishi M, Kawamoto S. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol 1977;39: 244-249. (Pubitemid 8043841)
39. Janssen F, Kunst AE. Cohort patterns in mortality trends among the elderly in seven European countries, 1950-1999. Int J Epidemiol 2005;34:1149-1159.
40. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedelijkovic S, Nissinen A, Toshima H. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995;274:131-136.
41. de Lorgeril M, Salen P, Paillard F, Laporte F, Boucher F, de Leiris J. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardi-ovasc Res 2002;54:503-515.
42. Opie LH, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 2007;28:1683-1693.
43. Morris W. Recent history of coronary disease. Lancet 1951;1:1-7.
44. White PD. Measuring the risk of coronary heart disease in adult population groups. The cardiologist enlists the epidemiologist. Am J Public Health Nations Health 1957;47:1-3.
45. Perkoff GT, Strand M. Race and presenting complaints in myocardial infarction. Am Heart J 1973;85:716-720.
46. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-940.
47. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007;297: 286-294.
48. Teo KK, Liu L, Chow CK, Wang X, Islam S, Jiang L, Sanderson JE, Rangarajan S, Yusuf S. Potentially modifiable risk factors associated with myocardial infarction in China: The INTERHEART China Study. Heart 2009;95:1857-1864.
49. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
50. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, Yusuf S. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 2008; 118:1929-1937.
51. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S. Tobacco use and risk of myo-cardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647-658.
52. Tibazarwa K, Ntyinyane L, Sliwa K, Gerntholz T, Wilkinson D, Stewart S. A time bomb or cardiovascular risk factors in South Africa: Results from the Heart of Soweto Study 'Heart Awareness days'. Int J Cardiol 2009;132:233-239.
53. Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the 'real world'. Nat Rev Cardiol 2009;6:489-492.
54. Figueredo VM. The time has come for physicians to take notice: the impact of psy-chosocial stressors on the heart. Am J Med 2009;122:704-712.
55. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-amorn C, Sato H, Yusuf S. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:953-962.
56. Walker AR, Sareli P. Coronary heart disease: outlook for Africa. J R Soc Med 1997; 90:23-27.
57. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004; 109:2655-2671.
58. Urbanization and urban air pollution. World Bank. http://www.worldbank. org/depweb/beyond/global/chapter10.html (6 January 2010). http://siteresources. worldbank.org/INTEAPREGTOPENVIRONMENrT/esources/chinacostofsolution.pdf (6 January 2010).
59. Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, Friel S, Groce N, Johnson A, Kett M, Lee M, Levy C, Maslin M, McCoy D, McGuire B, Montgomery H, Napier D, Pagel C, Patel J, de Oliveira JA, Redclift N, Rees H, Rogger D, Scott J, Stephenson J, Twigg J, Wolff J, Patterson C. Managing the health effects of climate change: Lancet and University College London Institute for Global Health Commission. Lancet 2009;373:1693-1733.
60. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996;334:413-419. (Pubitemid 26055840)
61. Barnighausen T, Welz T, Hosegood V, Batzing-Feigenbaum J, Tanser F, Herbst K, Hill C, Newell ML. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 2008;22:236-239.
62. Kahn K, Garenne ML, Collinson MA, Tollman SM. Mortality trends in a new South Africa: hard to make a fresh start. Scand J Public Health Suppl 2007;69:26-34.
63. Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 2009;6:120-127.
64. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dube MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation 2008;118:198-210.
65. Neel JV. Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'? Am J Hum Genet 1962;14:353-362.
66. Moore SE, Halsall I, Howarth D, Poskitt EM, Prentice AM. Glucose, insulin and lipid metabolism in rural Gambians exposed to early malnutrition. Diabet Med 2001;18:646-653.
67. Prentice AM, Rayco-Solon P, Moore SE. Insights from the developing world: thrifty genotypes and thrifty phenotypes. Proc Nutr Soc 2005;64:153-161.
68. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002;13:364-368.
69. Gardiner HM. Early environmental influences on vascular development. Early Hum Dev 2007;83:819-823.
70. Stoger R. The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? Bioessays 2008;30:156-166.
71. Speakman JR. Thrifty genes for obesity and the metabolic syndrome-time to call off the search? Diab Vasc Dis Res 2006;3:7-11.
72. Speakman JR. Thrifty genes for obesity, an attractive but flawed idea and an alternative perspective: the 'drifty gene' hypothesis. Int J Obes (Lond) 2008;32: 1611-1617.
73. Corbett SJ, McMichael AJ, Prentice AM. Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis. Am J Hum Biol 2009;21:587-598.
74. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-2753.
75. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Multiple bio-markers for the prediction of first major cardiovascular events and death. N Engl J Med 2006;355:2631-2639.
76. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006; 355:2615-2617.
77. Lindholm LH, Mendis S. Prevention of cardiovascular disease in developing countries. Lancet 2007;370:720-722. (Pubitemid 47320784)
78. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust 2005;182:66-69.
79. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398.
80. Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-1351.
81. Mendis S, Fuster V. National policies and strategies for noncommunicable diseases. Nat Rev Cardiol 2009;6:723-727.
82. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Rother J, Wilson PW. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-189.
83. Smith SC Jr. Risk factors for myocardial infarction in Latin America: sobrepeso y obesidad. Circulation 2007;115:1061-1063.
84. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-1206.
85. Poole-Wilson PA. Millennium development goals: an unbalanced approach to global health. Nat Clin Pract Cardiovasc Med 2007;4:289.
86. Fuster V, Voute J, Hunn M, Smith SC Jr. Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation 2007;116: 1966-1970.